Pages: 27 - 32

Authors: Daniel W. MUNDY and Tatjana JEVREMOVIC

Abstract

For a large number of women who are diagnosed with breast cancer every year, the available treatment options are effective, though physically and mentally taxing. This work is a starting point of a study of the efficacy of boron neutron capture therapy as an alternative treatment for HER-2+ breast tumors. Using HER-2-specific monoclonal antibodies coupled with a boron-rich oligomeric phosphate diester, it may be possible to deliver sufficient amounts of ¹⁰B to a tumor of the breast to allow for selective cell destruction via irradiation by thermal neutrons. A comprehensive computational model (MCNP) for thermal neutron irradiation of the breast is described, as well as the results of calculations made using this model, in order to determine the optimum boron concentration within the tumor for an effective boron neutron capture therapy treatment, as compared with traditional X-ray radiotherapy. The results indicate that a boron concentration of 50-60 mg per gram of tumor tissue is optimal when considering treatment times, dose distributions and skin sparing. However, these results are based upon best-guess assumptions that must be experimentally verified.

Key words: boron neutron capture therapy, breast cancer, MCNP, oligomeric phosphate diester

FULL PAPER IN PDF FORMAT (509KB)